<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant glycosylation is a common feature of many <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>About 15% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> show the microsatellite instability (MSI) phenotype that is associated with a high frequency of biallelic frameshift mutations in the A10 coding <z:chebi fb="0" ids="29075">mononucleotide</z:chebi> microsatellite of the transforming growth factor beta receptor 2 (TGFBR2) gene </plain></SENT>
<SENT sid="2" pm="."><plain>If and how impaired TGFBR2 signaling in MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells affects cell surface glycan pattern is largely unexplored </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we used the TGFBR2-deficient MSI colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cell line HCT116 as a model system </plain></SENT>
<SENT sid="4" pm="."><plain>Stable clones conferring <z:chebi fb="1" ids="50845">doxycycline</z:chebi> (dox)-inducible expression of a single copy <z:mp ids='MP_0002169'>wildtype</z:mp> TGFBR2 transgene were generated by recombinase-mediated cassette exchange (RMCE) </plain></SENT>
<SENT sid="5" pm="."><plain>In two independent clones, dox-inducible expression of <z:mp ids='MP_0002169'>wildtype</z:mp> TGFBR2 protein and reconstitution of its signaling function was shown </plain></SENT>
<SENT sid="6" pm="."><plain>Metabolic labeling experiments using the tritiated <z:chebi fb="0" ids="26667">sialic acid</z:chebi> precursor <z:chebi fb="0" ids="17122">N-acetyl-D-mannosamine</z:chebi> (ManNAc) revealed a significant decline (∼30%) of its incorporation into newly synthesized sialoglycoproteins in a TGFBR2-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>In particular, we detected a significant decrease of sialylated ß1-integrin upon reconstituted TGFBR2 signaling which did not influence ß1-integrin protein turnover </plain></SENT>
<SENT sid="8" pm="."><plain>Notably, TGFBR2 reconstitution did not affect the transcript levels of any of the known human sialyltransferases when examined by real-time RT- PCR analysis </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that reconstituted TGFBR2 signaling in an isogenic MSI cell line model system can modulate sialylation of cell surface proteins like ß1-integrin </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, our model system will be suitable to uncover the underlying molecular mechanisms of altered MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> glycobiology </plain></SENT>
</text></document>